When should a fascia iliaca block be performed in patients with acute hip fracture, and is it cost‑effective compared with standard opioid‑based analgesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fascia Iliaca Block for Hip Fracture: Timing and Cost-Effectiveness

Fascia iliaca compartment block (FICB) should be performed immediately upon admission to the emergency department for all patients with acute hip fracture, and a second block should be administered at the time of surgery (provided at least 6 hours have elapsed between blocks). This approach provides superior pain control, reduces opioid consumption, decreases complications including delirium and chest infections, and is likely cost-effective 1, 2, 3.

When to Perform the Block

Emergency Department Administration

The FICB should be administered as part of multimodal analgesia as soon as the patient arrives in the emergency department, ideally before radiographic confirmation if hip fracture is clinically suspected 1, 2. The 2024 WSES guidelines and 2021 Association of Anaesthetists guidelines both strongly support this early intervention, with evidence showing pain reduction within 30 minutes of block placement 1, 2.

Perioperative Administration

A second single-shot nerve block should be given at the time of surgery, ensuring at least 6 hours have passed since the initial ED block 2. This can be administered:

  • Before positioning for spinal anesthesia (may reduce need for additional sedation)
  • As a supplement to general or spinal anesthesia
  • Using either femoral or fascia iliaca approach (the latter may provide better incisional analgesia) 2

Technical Approach

  • Ultrasound-guided placement is recommended to increase accuracy and adequacy of analgesia 2
  • Single-shot technique is preferred over continuous blocks in UK/US practice, as continuous techniques may delay remobilization 2
  • Typical dosing: 30-40 mL bolus of 0.25% bupivacaine with 1:200,000 epinephrine 1

Clinical Benefits Supporting Use

The evidence demonstrates multiple morbidity and mortality benefits:

Pain Control

A Cochrane review of 49 trials (3,061 patients) showed peripheral nerve blocks reduced pain on movement within 30 minutes and provided superior analgesia compared to opioids 1. A systematic review of 27 RCTs (2,478 patients) confirmed FICB provides adequate pain relief compared to conventional methods 1.

Reduced Complications

Critical for mortality and morbidity reduction:

  • Decreased risk of acute confusional state/delirium 1
  • Reduced chest infections 1
  • Earlier time to first mobilization 1
  • Does not negatively impact cognitive status even in patients with moderate cognitive impairment 1

Opioid Reduction

Multiple studies demonstrate significant morphine-sparing effects:

  • Garlich et al. (725 patients ≥65 years): Preoperative fascia iliaca block patients consumed less morphine with low rates of opioid-related adverse events 1
  • Thompson et al.: Statistically significant decrease in morphine consumption (0.4 mg vs 19.4 mg, P=0.05) with 31% increase in patient satisfaction 1
  • Schulte et al.: Single perioperative FICB decreased opioid consumption and increased likelihood of discharge home 1

Cost-Effectiveness Evidence

Yes, FICB is likely cost-effective. The Cochrane review specifically noted that peripheral nerve blocks "probably costs" less than standard care 1. While the evidence statement is cautious ("probably"), this is based on:

  • Reduced opioid consumption and associated side effects
  • Decreased complications (delirium, chest infections)
  • Earlier mobilization
  • Shorter time to discharge home
  • Reduced need for rescue analgesia

The cost-effectiveness derives from preventing expensive complications (delirium management, pneumonia treatment, extended hospital stays) rather than direct cost savings from the procedure itself. The technique requires minimal additional equipment and can be performed by emergency physicians with brief training 2.

Safety Profile

The procedure demonstrates excellent safety:

  • Very few adverse effects reported across multiple systematic reviews 1
  • 90% success rate in prehospital settings 4
  • Not contraindicated in anticoagulated patients 2
  • Can be performed safely by practitioners of varying experience levels 2

Common Pitfalls to Avoid

  1. Delaying the block until radiographic confirmation: Administer based on clinical suspicion in the ED
  2. Using continuous nerve block techniques: These may delay remobilization and lack evidence in UK/US practice 2
  3. Forgetting the 6-hour interval: Ensure adequate time between ED and surgical blocks
  4. Relying solely on the block: FICB should be part of multimodal analgesia, not monotherapy
  5. Using pericapsular nerve group (PENG) blocks as first-line: These have not been compared with FICB in trials and do not provide analgesia to the surgical incision site 2

Algorithm for Implementation

For ALL hip fracture patients:

  1. Administer FICB in ED immediately upon arrival (or prehospital if available)
  2. Use ultrasound guidance when possible
  3. Combine with scheduled non-opioid analgesics (acetaminophen, NSAIDs if not contraindicated)
  4. Reserve opioids for breakthrough pain only
  5. Administer second block at time of surgery (≥6 hours after first block)
  6. Continue multimodal analgesia postoperatively

This approach is supported by strong evidence from the 2024 WSES guidelines [1-1], 2022 AAOS guidelines 3, and 2021 Association of Anaesthetists guidelines 2, all representing the most current expert consensus on hip fracture management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.